Esperion Therapeutics | ESPR - Market Capitalization


Esperion Therapeutics reported $579.2M in Market Capitalization this May of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 364.22B 20.46B May/2026
Alnylam Pharmaceuticals USD 44.15B 8.39B Mar/2026
Alterity Therapeutics Limited AUD 40M 16M May/2026
Amarin USD 290M 51M Dec/2025
Amgen USD 189.89B 13.64B Mar/2026
Biogen USD 26.9B 1.09B Mar/2026
BioMarin Pharmaceutical USD 10.18B 683M May/2026
Cipla INR 1.15T 162.77B May/2026
CSL USD 55.89B 20.42B Dec/2025
Cytokinetics USD 9.16B 975M May/2026
Daiichi Sankyo JPY 6.34T 62.51B Dec/2025
Eli Lilly USD 869.02B 146.97B Mar/2026
Esperion Therapeutics USD 885M 351M Dec/2025
Geron USD 946M 9M May/2026
Halozyme Therapeutics USD 8.56B 905M May/2026
Heron Therapeutics USD 238M 7M Dec/2025
Ionis Pharmaceuticals USD 12.46B 356M Mar/2026
Merck USD 297.1B 35.84B Mar/2026
Moderna USD 20.15B 8.53B Mar/2026
Nektar Therapeutics USD 15.62B 14.76B May/2026
Pfizer USD 147.4B 6.42B May/2026
PTC Therapeutics USD 4.94B 698M May/2026
Regeneron Pharmaceuticals USD 81.68B 560M Mar/2026
Sanofi EUR 100.27B 605.48M Mar/2026
Sarepta Therapeutics USD 2.16B 123M May/2026
United Therapeutics USD 28.08B 2.9B May/2026
Vanda Pharmaceuticals USD 279M 6M Dec/2024